drugset / Trial / NCT07144085
Application of ⁶⁸Ga-FXX489 (NNS309) PET/CT Imaging in Diagnosis of Tumor Diseases.
NaSingle-groupOpen-labelDiagnostic
Summary
A new radiotracer, 68Ga-FXX489 (NNS309), has been developed for tracking fibroblast activation protein (FAP) and visualizing the tumor stroma. The purpose of the study is to explore the diagnostic value of 68Ga-FXX489 (NNS309) PET/CT imaging in oncological diseases, to assess its safety, imaging characteristics, and biodistribution after administration.
Timeline
- Start
- 2025-09-11
- Primary completion
- 2027-07-30
- Completion
- 2027-07-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | FAP-2286 | Diagnostic / imaging agent | 111 mbq | Intravenous |
| Subject | FAP-2286 | Diagnostic / imaging agent | 296 mbq | Intravenous |
| Subject | FXX489 | Diagnostic / imaging agent | 111 mbq | Intravenous |
| Subject | FXX489 | Diagnostic / imaging agent | 296 mbq | Intravenous |